Home

Kwality Pharmaceuticals Ltd PE Ratio

Image

Kwality Pharmaceuticals Ltd

NSE: KWALITYPHARMA

PE

31.5

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Kwality Pharmaceuticals Ltd is 31.5 as of 15 Jan 15:30 PM .
  • The P/E Ratio of Kwality Pharmaceuticals Ltd changed from 3.2 on March 2020 to 17.9 on March 2024 . This represents a CAGR of 41.10% over 5 years.
  • The Latest Trading Price of Kwality Pharmaceuticals Ltd is ₹ 988.45 as of 15 Jan 16:01 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Kwality Pharmaceuticals Ltd

No data available

Company Fundamentals for Kwality Pharmaceuticals Ltd

Image

Kwality Pharmaceuticals Ltd

NSE: KWALITYPHARMA

Share Price

₹ 988.45

-52.00 (-5.00%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Kwality Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Kwality Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 20251040.45
13 Jan 2025991.15
10 Jan 2025970.4
09 Jan 2025924.2
08 Jan 2025936.4
07 Jan 2025936.5
06 Jan 2025902.4
03 Jan 2025923.05
02 Jan 2025904.7
01 Jan 2025867.3

SWOT Analysis Of Kwality Pharmaceuticals Ltd

Strength

1

che

Weakness

0

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Kwality Pharmaceuticals Ltd

Asset Value vs Market Value of Kwality Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Kwality Pharmaceuticals Ltd1079
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Kwality Pharmaceuticals Ltd Explained

``

1079

Market cap

28

Earnings

31.5X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Kwality Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Kwality Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Kwality Pharmaceuticals Ltd

No data available

* All values are in %

About Kwality Pharmaceuticals Ltd

  • Kwality Pharmaceuticals Limited was Incorporated on May 4th 1983 when its founder Mr. Ramesh Arora was inspired to begin his own venture leaving behind the already flourishing family business of spinning and aromatics.
  • With little background of finished pharmaceuticals and high held spirits and will, he started this business.
  • He received his first drug license in 1981 approved for liquid oral manufacturing.
  • Presently, the Company has 48 different sections available at their production centres. Kwality Pharmaceuticals Ltd. are manufacturer of finished pharmaceutical formulations in a Liquid Orals, Dry Syrups, Tablets, Capsules, Sterile Powder for Injections and small volume injectables.
  • The Company has the most modern & sophisticated Plant, Equipment, technique, and workforce.

Kwality Pharmaceuticals Ltd News Hub

Kwality Pharmaceuticals consolidated net profit rises 54.24% in the June 2024 quarter

Net profit of Kwality Pharmaceuticals rose 54.24% to Rs 8.36 crore in the quarter ended June 2024 as

Read more

2024-08-12 00:00:00

Kwality Pharmaceuticals to discuss results

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 August 20

Read more

2024-08-06 00:00:00

Kwality Pharmaceuticals schedules AGM

Kwality Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held

Read more

2024-09-10 00:00:00

Kwality Pharmaceuticals to conduct AGM

Kwality Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held

Read more

2024-09-10 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Kwality Pharmaceuticals Ltd

What is the current PE Ratio of Kwality Pharmaceuticals Ltd?

The Current PE Ratio of Kwality Pharmaceuticals Ltd is 31.54 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Kwality Pharmaceuticals Ltd last year?

The PE Ratio of Kwality Pharmaceuticals Ltd was 16.47 last year, now the PE ratio is 31.54, showing a year-on-year growth of 91.5%.

What does the PE Ratio of Kwality Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Kwality Pharmaceuticals Ltd is 31.54. This ratio indicates that investors are willing to pay 31.54 times the earnings per share for each share of Kwality Pharmaceuticals Ltd.

What is the PE Ratio Growth of Kwality Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Kwality Pharmaceuticals Ltd grew by 91.5% whereas, the EPS ratio grew by 1.4.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions